|
(3356310) - Gefitinib - Concentration/Dosage 250 Mg, Pharmaceutical Form Coated Tablet, Oral Administration Route, (3167852) - Gemcitabine - Concentration/Dosage 1 G, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Vial-Ampule Presentation Form, Intravenous Administration Route, (3167526) - Hydroxyurea - Concentration/Dosage 500 Mg, Capsule Pharmaceutical Form, (3241971) - Idarubicin, Hydrochloride - Concentration/Dosage 10 Mg, Presentation Form Vial-Ampule + Diluent, (3169006) - Ifosfamide - Concentration/Dosage 1 G, 02/12/2025 - 18:03:57, (3292355) - Irinotecan, Hydrochloride - Concentration/Dosage 20 Mg/Ml, Pharmaceutical Form Injectable Solution, (3355721) - Letrozole - Concentration/Dosage 2.5 Mg, (3087638) - Leuprorelin, Acetate - Concentration/Dosage 22, Prefilled Syringe Presentation Form, Subcutaneous Administration Route, (4629841) - Leuprorelin, Acetate - Concentration/Dosage 45Mg, Pharmaceutical Form Lyophilized Powder + Diluent, (3184196) - Melphalan - Concentration/Dosage 2 Mg, Pharmaceutical Form Tablet, (3243397) - Mercaptopurine - Concentration/Dosage 50 Mg, (3243427) - Methotrexate - Concentration/Dosage 100 Mg/Ml, Parenteral Route Of Administration, (3167984) - Methotrexate - Concentration/Dosage 2, (3168000) - Methotrexate - Concentration/Dosage 25 Mg/Ml, Parenteral Or Intrathecal Route Of Administration, (3242072) - Mitoxantrone - Concentration/Dosage 2 Mg/Ml
|
